media mismarketing

1. Forster V. Covid-19 Vaccines Can’t Alter Your DNA, Here’s Why. Forbes. January 11, 2021. Accessed June 11, 2022. https://www.forbes.com/sites/victoriaforster/2021/01/11/covid-19-vaccines-cant-alter-your-dna-heres-why

2. Park JW, Lagniton PNP, Liu Y, Xu RH. mRNA vaccines for COVID-19: what, why and how. Int J Biol Sci. 2021; 17(6):1446-1460. doi:10.7150/ijbs.59233

3. Javier T. Granados-Riveron, Guillermo Aquino-Jarquin, Engineering of the current nucleoside-modified mRNA-LNP vaccines against SARS-CoV-2. Biomed. Pharmacother. 2021;142,111953. doi:10.1016/j.biopha.2021.111953

4. Kim SC, Sekhon SS, Shin WR, et al. Modifications of mRNA vaccine structural elements for improving mRNA stability and translation efficiency. Mol Cell Toxicol. 2022;18(1):1-8. doi:10.1007/s13273-021-00171-4 

5. Röltgen K, Nielsen SCA, Silva O, et al. Immune imprinting, breadth of variant recognition, and germinal center response in human SARS-CoV-2 infection and vaccination. Cell. 2022;185(6):1025-1040.e14. doi:10.1016/j.cell.2022.01.018

6. Bansal S, Perincheri S, Fleming T, et al. Cutting Edge: Circulating Exosomes with COVID Spike Protein Are Induced by BNT162b2 (Pfizer-BioNTech) Vaccination prior to Development of Antibodies: A Novel Mechanism for Immune Activation by mRNA Vaccines. J Immunol. 2021;207(10):2405-2410. doi:10.4049/jimmunol.2100637

7. Advance Purchase Agreement: European Commission and Pfizer-BioNTech. Published April 17, 2021. Accessed June 11, 2022. https://www.rai.it/dl/doc/2021/04/17/1618676600910_APA%20BioNTech%20Pfizer__.pdf

8. Assessment Report: Comirnaty. Committee for Medicinal Products for Human Use (CHMP). Published February 19, 2021. Accessed June 11, 2022. https://www.ema.europa.eu/en/documents/assessment-report/comirnaty-epar-public-assessment-report_en.pdf

9. Chen T-H, Potapov V, Dai N, Ong JL, Roy B. Improving the fidelity of uridine analog incorporation during in vitro transcription. bioRxiv: the preprint server for biology. Published online April 13, 2022. doi:10.1101/2022.04.12.488100

10. Mauro, VP. Codon Optimization in the Production of Recombinant Biotherapeutics: Potential Risks and Considerations. BioDrugs. 2018; 32:69-81. doi:10.1007/s40259-018-0261-x

11. Plotkin JB, Kudla G. Synonymous but not the same: the causes and consequences of codon bias. Nat Rev Genet. 2011;12(1):32-42. doi:10.1038/nrg2899

12. Wu, M, Tinoco Jr, I. RNA folding causes secondary structure rearrangement. Proc. Natl. Acad. Sci. U.S.A.. 1998;95(20):11555-11560. doi:10.1073/pnas.95.20.11555

13. McKernan K, Kyriakopoulos, A, McCullough, P. Differences in Vaccine and SARS-CoV-2 Replication Derived mRNA: Implications for Cell Biology and Future Disease. 2021. doi:10.31219/osf.io/bcsa6

14. ProImmune thinkpeptides. Katerina Alexaki: Effects of codon optimization on biotherapeutics: Implications for immunogenicity. Published September 27, 2019. Accessed June 11, 2022. https://www.youtube.com/watch?v=aZwYEpumQRU

15. Slater, J, Westbrook C. Who will get a Covid booster jab and when will boosters start being rolled out? Metro. September 16, 2021. Accessed June 11, 2022. https://metro.co.uk/2021/09/16/covid-vaccine-who-will-get-a-booster-jab-and-when-will-they-start-3-15269440/

16. Ambati BK, Varshney A, Lundstrom K, et al. MSH3 Homology and Potential Recombination Link to SARS-CoV-2 Furin Cleavage Site. Front. Virol. 2022;2. doi:10.3389/fviro.2022.834808

17. Hossain MG, Tang Y-d, Akter S, Zheng C. Roles of the polybasic furin cleavage site of spike protein in SARS-CoV-2 replication, pathogenesis, and host immune responses and vaccination. J Med Virol. 2022;94:1815-1820. doi:10.1002/jmv.27539

18. Skopec R. Coronavirus is a Biological Warfare Weapon. J Clin Med Case Rep. 2020;1(2):1-6. doi:10.24966/CSMC-8801/100103

19. Cheng MH, Zhang S, Porritt RA, et al. Superantigenic character of an insert unique to SARS-CoV-2 spike supported by skewed TCR repertoire in patients with hyperinflammation. Proc. Natl. Acad. Sci. U.S.A.. 2020;117(41):25254-25262. doi:10.1073/pnas.2010722117

20. Macphail S. Superantigens: mechanisms by which they may induce, exacerbate and control autoimmune diseases. Int Rev Immunol. 1999;18(1-2):141-180. doi:10.3109/08830189909043022

21. Perez JC, Moret-Chalmin C, Montagnier L. Towards the emergence of a new form of the neurodegenerative Creutzfeldt-Jakob disease: Twenty six cases of CJD declared a few days after a COVID-19 “vaccine” Jab. 2022. doi:10.13140/RG.2.2.12035.37924

22. Prion Diseases. John Hopkins Medicine. Accessed June 11, 2022. https://www.hopkinsmedicine.org/health/conditions-and-diseases/prion-diseases

23. Gallagher J. Covid vaccine: What you need to know about vaccine safety. BBC. December 9, 2020. Accessed June 11, 2022. https://www.bbc.co.uk/news/health-55216047

24. Healy D. Disappeared in Argentina. Accessed June 11, 2022. https://davidhealy.org/disappeared-in-argentina/

25. 125742_S1_M5_5351_c4591001-fa-interim-adverse-events. Pfizer. Accessed June 11, 2022. https://pdata0916.s3.us-east-2.amazonaws.com/pdocs/060122/125742_S1_M5_5351_c4591001-fa-interim-adverse-events.pdf

26. BNT162b2: Vaccines and Related Biological Products Advisory Committee October 26, 2021 Meeting Document. VRBPAC. Accessed June 11, 2022. https://www.fda.gov/media/153409/download

27. Signal assessment report on Myocarditis, pericarditis with Tozinameran (COVID-19 mRNA vaccine (nucleosidemodified) – COMIRNATY). EMA. December 2, 2021. Accessed June 11, 2022. https://www.ema.europa.eu/en/documents/prac-recommendation/signal-assessment-report-myocarditis-pericarditis-tozinameran-covid-19-mrna-vaccine_en.pdf

28. Comirnaty (COVID-19 mRNA Vaccine) Risk Management Plan V.5.0. EMA. Accessed June 11, 2022. https://www.ema.europa.eu/en/documents/rmp-summary/comirnaty-epar-risk-management-plan_en.pdf

29. Weissman J. Who regulates the regulator? Heart Publications. April 2, 2022. Accessed June 11, 2022. https://www.heartpublications.co.uk/who-regulates-the-regulator/

30. CBER assessment of a single booster dose of the Pfizer-BioNTech COVID-19 Vaccine (0.3 mL) administered to individuals 16 to 17 years of age after completion of a primary vaccination series with the Pfizer-BioNTech COVID-19 Vaccine or COMIRNATY. FDA. December 8, 2021. Accessed June 11, 2022. https://www.fda.gov/media/154869/download

31. Perez JL. Efficacy & Safety of BNT162b2 booster - C4591031 2 month interim analysis. November 19, 2021. Accessed June 11, 2022. https://www.cdc.gov/vaccines/acip/meetings/downloads/slides-2021-11-19/02-COVID-Perez-508.pdf

32. Frenck RW Jr, Klein NP, Kitchin N, et al. Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents. N Engl J Med. 2021;385(3):239-250. doi:10.1056/NEJMoa2107456

33. Antibody Testing Is Not Currently Recommended to Assess Immunity After COVID-19 Vaccination: FDA Safety Communication. FDA. May 19, 2021. Accessed June 11, 2022. https://www.fda.gov/medical-devices/safety-communications/antibody-testing-not-currently-recommended-assess-immunity-after-covid-19-vaccination-fda-safety

34. FDA-CBER-2021-5683-0123168-to-0126026_125742_S1_M5_c4591001-A-D-adva.zip (.xpt). Pfizer. Accessed June 11, 2022.  https://pdata0916.s3.us-east-2.amazonaws.com/pdocs/050222/FDA-CBER-2021-5683-0123168+to+-0126026_125742_S1_M5_c4591001-A-D-adva.zip

35. Understanding cycle threshold (Ct) in SARS-CoV-2 RT-PCR. Public Health England. October 2020. Accessed June 11, 2022. https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/926410/Understanding_Cycle_Threshold__Ct__in_SARS-CoV-2_RT-PCR_.pdf

36. As Pressure Mounts, Help the NHS by Getting Boosted Now. Cheshire Clinical Commissioning Group. January 10, 2022. Accessed June 11, 2022. https://www.cheshireccg.nhs.uk/news/news-stories/as-pressure-mounts-help-the-nhs-by-getting-boosted-now/

37. Covid: Television advert launched urging people aged 50 and under to get vaccine. ITV. April 25, 2021. Accessed June 11, 2022. https://www.itv.com/news/2021-04-25/covid-television-advert-launched-urging-people-aged-50-and-under-to-get-vaccine

38. Gundry SR. Abstract 10712: Observational Findings of PULS Cardiac Test Findings for Inflammatory Markers in Patients Receiving mRNA Vaccines. Circulation. 2021;144:A10712. doi:10.1161/circ.144.suppl_1.10712

39. PULs – Test Result Package – v4. PULs Cardiac Test. August 15, 2009. Accessed June 11, 2022. https://www.mdbriefcase.com/wp-content/uploads/2019/08/PULS-Test-Result-Package.pdf

40. Bhakdi S, Burkhardt A. On COVID vaccines: why they cannot work, and irrefutable evidence of their causative role in deaths after vaccination. December 15, 2021. Accessed June 11, 2022. https://doctors4covidethics.org/on-covid-vaccines-why-they-cannot-work-and-irrefutable-evidence-of-their-causative-role-in-deaths-after-vaccination/

41. Gong S, Ruprecht RM. Immunoglobulin M: An Ancient Antiviral Weapon – Rediscovered. Front. Immunol. 2020;11. doi:10.3389/fimmu.2020.01943

42. Hoffmann M, Krüger N, Schulz S, et al. The Omicron variant is highly resistant against antibody-mediated neutralization: Implications for control of the COVID-19 pandemic. Cell. 2022;185(3):447-456.e11. doi:10.1016/j.cell.2021.12.032

43. Antibody Essentials Part 1: Antibody Basics. Cell Signal Technology (official blog). Accessed June 11, 2022. https://blog.cellsignal.com/antibody-essentials-part-1-antibody-basics

44. Genomic epidemiology of SARS-CoV-2 with subsampling focused globally over the past 6 months. Nextstrain. Accessed June 11, 2022. https://nextstrain.org/ncov/open/global/6m

45. Guerin P, Yahi N, Azzaz F, et al. Distinct evolution of infection-enhancing and neutralizing epitopes in the spike protein of SARSCoV-2 variants (alpha, beta, gamma, delta, lambda and mu) : a structural and molecular epidemiology. November 8, 2021. doi:10.21203/rs.3.rs-1054360/v1

46. Dumphreys L, Alvares D. Brazil city offers COVID shots to all 18-60 as part of test. AP News. May 16, 2021. Accessed June 11, 2022. https://apnews.com/article/europe-brazil-coronavirus-vaccine-immunizations-coronavirus-pandemic-2b4d4eaadbe4420cb5112432242b7c4f

47. Worshiping the Golden Calf. Wikimedia Commons. Accessed June 11, 2021. https://commons.wikimedia.org/wiki/File:Worshiping_the_golden_calf.jpg

On Saturday 11 June 2022, I presented my talk, Examining the Media's Medical Mismarketing, at the Health & Truth Summit on Media Manipulation & Control in Motherwell, Scotland. I have written a review of the summit for Heart Publications, which is available online. My presentation investigated the credibility of the claims used to market the experimental COVID-19 genetic vaccines. Please visit healthandtruth.org to watch all the talks.